MODIFICATION OF THE COMPLEMENT BINDING-PROPERTIES OF POLYSTYRENE - EFFECTS OF END-POINT HEPARIN ATTACHMENT

被引:45
作者
NILSSON, UR
LARM, O
NILSSON, B
STORM, KE
ELWING, H
EKDAHL, KN
机构
[1] UNIV LINKOPING, INST APPL PHYS, LINKOPING, SWEDEN
[2] CARMEDA MEDICARB, STOCKHOLM, SWEDEN
关键词
D O I
10.1111/j.1365-3083.1993.tb02564.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In recent years, conjugation of heparin to biomaterials has been shown to improve its biocompatibility. The purpose of the present work was to compare complement activation and binding of C3 to unmodified and heparin-treated polystyrene surfaces of microtitre plates. When polystyrene was incubated with human serum, C3 was deposited on the surface by both adsorption and binding dependent on activation of the classical (CPW) and alternative (APW) pathways. After end-point attachment of heparin, significant C3 deposition, although at reduced levels, occurred only by CPW-mediated mechanisms, while adsorption and APW-mediated binding were strongly reduced. Generally, the modified surface bound lower amounts of protein, e.g. serum albumin and IgG, than the unmodified. By contrast, it had increased affinity for C1q which leads to binding of C1 and activation of complement via the CPW. Nevertheless, the net effect of the surface modification on the complement reaction was an overall reduction of C3 binding due to obliteration of APW. This can be related to an enhanced factor H/I-dependent down-regulation of C3b and to the lowered protein-adsorbing property of the surface, both of which have inhibitory effects on APW and on the C3 shunt-dependent activation of the complement system.
引用
收藏
页码:349 / 354
页数:6
相关论文
共 30 条
[1]   PLASMA-PROTEIN ADSORPTION - THE BIG 12 [J].
ANDRADE, JD ;
HLADY, V .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1987, 516 :158-172
[2]  
APPLE DJ, 1984, OPHTHALMOLOGY, V91, P403
[3]   TREATMENT OF ACUTE RESPIRATORY-FAILURE BY EXTRACORPOREAL CARBON-DIOXIDE ELIMINATION PERFORMED WITH A SURFACE HEPARINIZED ARTIFICIAL LUNG [J].
BINDSLEV, L ;
EKLUND, J ;
NORLANDER, O ;
SWEDENBORG, J ;
OLSSON, P ;
NILSSON, E ;
LARM, O ;
GOUDA, I ;
MALMBERG, A ;
SCHOLANDER, E .
ANESTHESIOLOGY, 1987, 67 (01) :117-120
[4]   EXTRACORPOREAL CARBON-DIOXIDE REMOVAL PERFORMED WITH SURFACE-HEPARINIZED EQUIPMENT IN PATIENTS WITH ARDS [J].
BINDSLEV, L ;
BOHM, C ;
JOLIN, A ;
JONZON, KH ;
OLSSON, P ;
RYNIAK, S .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1991, 35 :125-131
[5]   COMPLEMENT ACTIVATION IN EXTRACORPOREAL CIRCUITS [J].
CHENOWETH, DE .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 516 :306-313
[6]   COMPLEMENT ACTIVATION DURING CARDIOPULMONARY BYPASS - EVIDENCE FOR GENERATION OF C3A AND C5A ANAPHYLATOXINS [J].
CHENOWETH, DE ;
COOPER, SW ;
HUGLI, TE ;
STEWART, RW ;
BLACKSTONE, EH ;
KIRKLIN, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (09) :497-503
[7]  
HAMMER CH, 1981, J BIOL CHEM, V256, P3995
[8]  
HESSING M, 1990, J IMMUNOL, V144, P204
[9]   BIO-MEDICAL POLYMERS DIFFER IN THEIR CAPACITY TO ACTIVATE COMPLEMENT [J].
JANATOVA, J ;
CHEUNG, AK ;
PARKER, CJ .
COMPLEMENT AND INFLAMMATION, 1991, 8 (02) :61-69
[10]   SURFACE-ASSOCIATED HEPARIN INHIBITS ZYMOSAN-INDUCED ACTIVATION OF THE HUMAN ALTERNATIVE COMPLEMENT PATHWAY BY AUGMENTING THE REGULATORY ACTION OF THE CONTROL PROTEINS ON PARTICLE-BOUND C3B [J].
KAZATCHKINE, MD ;
FEARON, DT ;
SILBERT, JE ;
AUSTEN, KF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 150 (05) :1202-1215